|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2001-9-11
|
|
pubmed:abstractText |
We previously reported that the new disease modifying antirheumatic drug leflunomide resulted in significant improvement in functional ability compared with placebo and sulfasalazine in a 6 month double blind, randomized, Phase III trial in rheumatoid arthritis (RA). The current study compared functional disability in cohorts of patients with RA from the initial study who volunteered to continue treatment with leflunomide or sulfasalazine.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
pubmed-author:European Leflunomide Study Group,
pubmed-author:JonesPP,
pubmed-author:KaldenJ RJR,
pubmed-author:KvienT KTK,
pubmed-author:OesPP,
pubmed-author:RosenburgRR,
pubmed-author:RozmanBB,
pubmed-author:SchattenkirchnerMM,
pubmed-author:ScottD LDL,
pubmed-author:SmolevJ KJK,
pubmed-author:WilliamsB DBD,
pubmed-author:WilliamsR BRB
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1983-91
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11550964-Adolescent,
pubmed-meshheading:11550964-Adult,
pubmed-meshheading:11550964-Aged,
pubmed-meshheading:11550964-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:11550964-Arthritis, Rheumatoid,
pubmed-meshheading:11550964-Cohort Studies,
pubmed-meshheading:11550964-Double-Blind Method,
pubmed-meshheading:11550964-Drug Administration Schedule,
pubmed-meshheading:11550964-Female,
pubmed-meshheading:11550964-Humans,
pubmed-meshheading:11550964-Isoxazoles,
pubmed-meshheading:11550964-Long-Term Care,
pubmed-meshheading:11550964-Male,
pubmed-meshheading:11550964-Middle Aged,
pubmed-meshheading:11550964-Pain Measurement,
pubmed-meshheading:11550964-Patient Satisfaction,
pubmed-meshheading:11550964-Probability,
pubmed-meshheading:11550964-Prognosis,
pubmed-meshheading:11550964-Range of Motion, Articular,
pubmed-meshheading:11550964-Severity of Illness Index,
pubmed-meshheading:11550964-Sulfasalazine,
pubmed-meshheading:11550964-Time Factors,
pubmed-meshheading:11550964-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
|
|
pubmed:affiliation |
Department of Internal Medicine III, University of Erlangen-Nuremberg, Germany. joachim.kalden@med3.med.uni-erlangen.de
|
|
pubmed:publicationType |
Journal Article,
Guideline,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Practice Guideline,
Clinical Trial, Phase III
|
